Cited by 76Pancreatic function and diabetesCellular transport and secretionDiabetes Treatment and Management

Synaptotagmin-7 phosphorylation mediates GLP-1–dependent potentiation of insulin secretion from β-cells

Open access
Wu, Bingbing, Wei, Shunhui, Petersen, Natalia, Ali, Yusuf, Wang, Xiaorui, Bacaj, Taulant, Rorsman, Patrik, Hong, Wanjin +2 more·2015·Proceedings of the National Academy of Sciences

Abstract

Significance: The present study shows that glucagon-like peptide-1 (GLP-1) potentiates insulin release by inducing the PKA-mediated phosphorylation of synaptotagmin-7 in pancreatic β-cells, thereby documenting that the hormone GLP-1 acts by directly enhancing Ca 2+ -triggered insulin exocytosis. PKA phosphorylates synaptotagmin-7 at a single serine residue in the linker between the synaptotagmin-7 transmembrane region and its C-terminal C 2 domains that bind Ca 2+ ; accordingly, PKA phosphorylation of synaptotagmin-7 enhances insulin secretion without changing the Ca 2+ dependence of secretion. The study documents that the efficacy of a synaptotagmin can be modulated by phosphorylation and highlights the importance of synaptotagmin-7 in mediating glucose-stimulated insulin secretion. Given the importance of enhancing β-cell function in the treatment of diabetes, the present findings may offer new pathways for developing future therapeutic strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1513004112

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many potentiators of insulin secretion exert a direct effect on late steps of exocytosis in addition to stimulating β-cell electrical activity.

    “Many potentiators of insulin secretion exert a direct effect on late steps of exocytosis in addition to stimulating β-cell electrical activity.”

    From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [735]

    The Significance section reports that GLP-1 directly enhances Ca²⁺-triggered insulin exocytosis, supporting the claim for one potentiator. The Discussion also describes GLP-1 increasing calcium through Epac2, but it does not establish that many potentiators both act on late exocytotic steps and stimulate β-cell electrical activity. Page numbers are unavailable in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Somatostatin's inhibitory effect may involve dephosphorylation of the same serine residue in Syt7 that is phosphorylated in the presence of GLP-1.

    “There is some evidence that somatostatin’s inhibitory effect on exocytosis is mediated by activation of the protein phosphatase calcineurin (543), possibly by dephosphorylation of the same serine residue in Syt7 that is phosphorylated in the presence of GLP-1 (735).”

    From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [735]

    The Results identify serine-103 as the Syt7 residue phosphorylated in response to GLP-1 signaling, and the Discussion links that phosphorylation to enhanced exocytosis. The paper does not address whether somatostatin inhibits exocytosis by dephosphorylating that residue, so it supports only the GLP-1 side of the proposed mechanism. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • GLP-1 stimulates exocytosis by cAMP-dependent activation of PKA, which phosphorylates synaptotagmin-7 at serine-103.

    “For example, GLP-1 stimulates exocytosis via Epac2 (170) and by cAMP-dependent activation of PKA, which phosphorylates synaptotagmin-7 at serine-103 (735).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 19

  1. [29]Gauthier BR, Wollheim CB (2008) Synaptotagmins bind calcium to release insulin. Am J Physiol Endocrinol Metab 295(6):E1279 -E1286.
  2. [30]Ramalingam L, et al. (2012) Doc2b is a key effector of insulin secretion and skeletal muscle insulin sensitivity. Diabetes 61(10):2424 -2432.
  3. [31]Fujimoto K, et al. (2002) Piccolo, a Ca2 + sensor in pancreatic beta-cells. Involvement of cAMP-GEFII.Rim2. Piccolo complex in cAMP-dependent exocytosis. J Biol Chem 277(52):50497 -50502.
  4. [32]Walter AM, Groffen AJ, Sørensen JB, Verhage M (2011) Multiple Ca2 + sensors in secretion: Teammates, competitors or autocrats? Trends Neurosci 34(9):487 -497.
  5. [35]Shu Y, Liu X, Yang Y, Takahashi M, Gillis KD (2008) Phosphorylation of SNAP-25 at Ser187 mediates enhancement of exocytosis by a phorbol ester in INS-1 cells. J Neurosci 28(1):21 -30.
  6. [36]Cai Q, et al. (2010) Snapin-regulated late endosomal transport is critical for efficient autophagy-lysosomal function in neurons. Neuron 68(1):73 -86.
  7. [37]Cai Q, Sheng ZH (2011) Uncovering the role of Snapin in regulating autophagylysosomal function. Autophagy 7(4):445 -447.
  8. [38]Chheda MG, Ashery U, Thakur P, Rettig J, Sheng ZH (2001) Phosphorylation of Snapin by PKA modulates its interaction with the SNARE complex. Nat Cell Biol 3(4):331 -338.
  9. [40]Fernández-Chacón R, et al. (2001) Synaptotagmin I functions as a calcium regulator of release probability. Nature 410(6824):41 -49.
  10. [41]Popoli M, et al. (1997) Long-term blockade of serotonin reuptake affects synaptotagmin phosphorylation in the hippocampus. Mol Pharmacol 51(1):19 -26.
  11. [42]Hilfiker S, Pieribone VA, Nordstedt C, Greengard P, Czernik AJ (1999) Regulation of synaptotagmin I phosphorylation by multiple protein kinases. J Neurochem 73(3): 921 -932.
  12. [43]Verona M, Zanotti S, Schäfer T, Racagni G, Popoli M (2000) Changes of synaptotagmin interaction with t-SNARE proteins in vitro after calcium/calmodulin-dependent phosphorylation. J Neurochem 74(1):209 -221.
  13. [44]Lee BH, et al. (2004) WNK1 phosphorylates synaptotagmin 2 and modulates its membrane binding. Mol Cell 15(5):741 -751.
  14. [45]Mori Y, Higuchi M, Hirabayashi Y, Fukuda M, Gotoh Y (2008) JNK phosphorylates synaptotagmin-4 and enhances Ca2 + -evoked release. EMBO J 27(1):76 -87.
  15. [47]Maximov A, Shin OH, Liu X, Südhof TC (2007) Synaptotagmin-12, a synaptic vesicle phosphoprotein that modulates spontaneous neurotransmitter release. J Cell Biol 176(1):113 -124.
  16. [48]Nagy G, et al. (2006) Different effects on fast exocytosis induced by synaptotagmin 1 and 2 isoforms and abundance but not by phosphorylation. J Neurosci 26(2):632 -643.
  17. [49]Brozzi F, et al. (2012) MyRIP interaction with MyoVa on secretory granules is controlled by the cAMP-PKA pathway. Mol Biol Cell 23(22):4444 -4455.
  18. [50]Maximov A, et al. (2008) Genetic analysis of synaptotagmin-7 function in synaptic vesicle exocytosis. Proc Natl Acad Sci USA 105(10):3986 -3991.
  19. [53]Lindau M, Neher E (1988) Patch-clamp techniques for time-resolved capacitance measurements in single cells. Pflugers Arch 411(2):137 -146.

Cited by

Sorted by citations

Authors
Wu, B., Wei, S., Petersen, N., Ali, Y., Wang, X., Bacaj, T., Rorsman, P., Hong, W., Südhof, T. C., & Han, W.
Affiliations
  • Agency for Science, Technology and Research (SG)
  • Howard Hughes Medical Institute (US)
  • Churchill Hospital (GB)
Venue
Proceedings of the National Academy of Sciences
Published
2015-07-27
Volume
112
Issue
32
Pages
9996-10001
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1702317583
Cited by
76
References
7
Citations by year
2026: 6 · 2025: 5 · 2024: 3 · 2023: 8 · 2022: 7 · 2021: 8 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 8 · 2016: 10 · 2015: 2
FWCI
9.40
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
Funders
HHS | NIH | National Institute of Mental Health (MH086403)
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
synaptotagmin 7, glucagon-like peptide-1, insulin secretion, pancreatic beta cells, protein kinase A, calcium-triggered exocytosis, glucose homeostasis, type 2 diabetes, GLP-1 receptor agonists, phosphomimetic mutant
MeSH terms
Glucagon-Like Peptide-1 Receptor, Exenatide, Insulin Secretion, Cyclic AMP, Amino Acid Sequence, Animals, Exocytosis, Colforsin, Glucose, Humans, Insulin, Molecular Sequence Data, Mutation, Peptides, Phosphorylation, Phosphoserine, Venoms, Conserved Sequence, Cyclic AMP-Dependent Protein Kinases, Receptors, Glucagon, Mice, Knockout, Evolution, Molecular, Insulin-Secreting Cells, Synaptotagmins, Rats, Glucagon-Like Peptide 1, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review